Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
19 Februari 2026, 15:34:26
Iron deficiency anaemia (IDA)
Iron deficiency anaemia (IDA) is a common haematological disorder caused by inadequate iron availability for erythropoiesis, leading to reduced haemoglobin synthesis. It is particularly prevalent among:
Young children
Women of reproductive age
Pregnant women
Etiology:
Nutritional deficiency: Inadequate dietary iron intake
Chronic blood loss: Menstrual bleeding, gastrointestinal bleeding (ulcers, polyps, malignancy), parasitic infections
Increased demand: Pregnancy, rapid growth in infants and adolescents
Malabsorption: Coeliac disease, bariatric surgery
Pathophysiology:
Iron is essential for haemoglobin synthesis, myoglobin, and iron-containing enzymes.
Iron deficiency reduces Hb production → microcytic, hypochromic red blood cells → impaired oxygen delivery to tissues.
Chronic deficiency may lead to developmental delays in children and reduced work capacity in adults.
Note: In children > 5 years, adult males, and non-menstruating women, iron deficiency anaemia usually suggests occult or overt blood loss until proven otherwise.
2. Risk Factors
Age: Infants, children under 5 years
Gender: Women of reproductive age
Pregnancy: Increased iron demand
Dietary insufficiency: Vegetarian diets, poverty, poor nutrition
Blood loss: Menorrhagia, gastrointestinal bleeding
Malabsorption syndromes: Coeliac disease, post-gastric surgery
Parasitic infections: Hookworm, schistosomiasis
Chronic illnesses: Chronic kidney disease, inflammatory bowel disease
3. Signs and Symptoms
General Symptoms
Fatigue, weakness, lethargy
Shortness of breath on exertion
Dizziness, palpitations
Headache
Pale skin, especially conjunctiva and palms
Specific Features of Chronic Iron Deficiency
Brittle nails (koilonychia)
Glossitis (smooth, inflamed tongue)
Angular cheilitis
Pica (craving for non-food substances)
Cognitive impairment in children
Poor growth and delayed development
4. Diagnostic Criteria
Parameter | Adults | Children |
Haemoglobin | <13 g/dL (men), <12 g/dL (non-pregnant women) | <11 g/dL (≥5 yrs), <10 g/dL (<5 yrs) |
MCV | <80 fL (microcytic) | <75 fL |
MCH | Low (hypochromic) | Low |
Serum ferritin | <15–30 µg/L | <12–15 µg/L |
Transferrin saturation | <16% | <16% |
Peripheral smear | Microcytosis, hypochromia, anisopoikilocytosis | Same |
Additional clues:
Raised red cell distribution width (RDW)
Reticulocyte count: low or inappropriately normal
Consider gastrointestinal workup if adult male or postmenopausal female
5. Investigations
Basic Laboratory Tests
Complete blood count (CBC)
Peripheral blood smear
Serum ferritin
Serum iron
Total iron-binding capacity (TIBC)
Transferrin saturation
Reticulocyte count
Additional Investigations (if indicated)
Stool for occult blood
Endoscopy / colonoscopy (adults with suspected GI bleeding)
Parasitology (hookworm, schistosomiasis)
Renal and liver function tests
Screen for celiac disease in malabsorption
6. Management
A. Non-Pharmacological Measures
1. Identify and Treat Cause
Exclude other causes of anaemia (B12, folate deficiency, chronic disease)
Address sources of blood loss
Treat underlying parasitic infections
2. Dietary Advice
Increase heme iron sources: liver, kidney, beef, poultry, fish
Increase non-heme iron sources: green leafy vegetables, dried beans, peas, fortified cereals, wholegrain bread
Increase iron absorption: vitamin C-rich foods (citrus, strawberries, guavas, broccoli)
Avoid tea or coffee with meals (polyphenols inhibit absorption)
For children: ensure age-appropriate iron intake
B. Pharmacological Treatment
i. Children <5 Years
Oral elemental iron: 1–2 mg/kg/dose, 8-hourly with meals
Follow-up Hb: After 14 days
If improving: continue and reassess in 28 days
Continue for 3 months after Hb normalization to replenish stores
ii. Adults
Ferrous sulfate BPC (170 mg ≈ 65 mg elemental iron) 8-hourly with meals
Ferrous fumarate (200 mg ≈ 65 mg elemental iron) 8-hourly with meals
Expected response: Hb rise ≥2 g/dL in 4 weeks
Continue for 3–6 months after normalization to restore iron stores
Avoid iron tablets within 4 hours of calcium supplements
iii. Pregnant Women
Ferrous sulfate BPC 170 mg 12-hourly
Supplementation crucial to prevent maternal and fetal anaemia
iv. Infants <6 months (<2.5 kg at birth)
Ferrous lactate 0.3 mL PO daily until 6 months
OR Ferrous gluconate syrup 0.8 mL PO daily until 6 months
7. Monitoring
Hb check: 2–4 weeks after starting therapy
MCV and ferritin: after 8–12 weeks
Assess adherence and side effects (constipation, nausea, dark stools)
If poor response: investigate for other causes (malabsorption, ongoing bleeding)
8. Prevention
Promote balanced diet rich in iron and vitamin C
Use fortified cereals and foods
Routine iron supplementation in pregnancy
Deworming programs for children in endemic areas
Screening for occult blood loss in adults at risk
9. Complications if Untreated
Severe anaemia → heart failure, growth retardation in children
Developmental delays
Reduced immunity → increased infections
Fatigue, poor work capacity
References
WHO. Iron deficiency anaemia: assessment, prevention and control. Geneva: WHO; 2001.
Hoffbrand AV, Moss PAH. Essential Haematology. 8th ed. Wiley-Blackwell; 2019.
McLean E, et al. Worldwide prevalence of anaemia. Public Health Nutr. 2009;12(4):444–454.
Camaschella C. Iron-deficiency anaemia. N Engl J Med. 2015;372:1832–1843.
Pasricha SR, et al. Diagnosis and management of iron deficiency anaemia. Br Med Bull. 2010;93:5–24.
Ministry of Health Tanzania. Standard Treatment Guidelines. Dar es Salaam: MoH; 2023.
Bothwell TH. Iron requirements in man. Nutr Rev. 2000;58:24–33.
